Regulatory Rapporteur September 2011
Volume 8 Issue 9
In This Issue
- FDA’s Bad Ad programme
- US drug safety reforms
- A new pathway for biosimilars
- Views from industry
- Canada news in brief
Please login to download articles. Non-members may download the Focus article.
| Title | Download | Category | Size | File |
|---|---|---|---|---|
| Regulatory Rapporteur September 2011 | Members | Full Issue | 2MB | |
| A regulatory visit to North America | Public | 471KB | ||
| Maple leaf news | Members | 462KB | ||
| Modernising the regulation of OTC medicines – Towards a tailored tool for the assessment of benefit and risk | Members | 499KB | ||
| The ABCs of PDUFA | Members | 502KB | ||
| The impact of a new regulatory pathway for biosimilars | Members | 576KB | ||
| The medical devices exchange | Members | 557KB | ||
| The veterinary medicines exchange | Members | 489KB | ||
| Veterinary medicines legislative review – The big debate | Members | 533KB | ||
| Views from the top | Members | 507KB |
